Log in to search using one of your social media accounts:

This page shows you the latest items in this publication.

Ryan Confident About Health Plan's Passage
Paul Ryan  expressed confidence that the Republican health-care plan will pass the House later this week, saying his party’s lawmakers are working to make changes to the bill to address remaining concerns, including providing more assistance to older Americans. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 20, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

A Prescription Blood Thinner Beat Aspirin at Preventing Recurrence of Blood Clots, Study Finds
A Canadian research team found low doses of the blood thinner rivaroxaban, marketed as Xarelto from Johnson& Johnson unit Janssen Pharmaceuticals, reduced the risk of blood clot recurrence by about 70% compared with aspirin, without increasing the risk of bleeding. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 19, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news

Young People to Pay Less Under GOP Health Plan, CBO Says
A federal analysis of a Republican health plan that shows it would leave millions more uninsured has a silver lining for GOP leaders: In general, premiums under their proposal would eventually come down for younger people. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 15, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

GOP Senators Say House Health Bill Won't Pass Without Changes
Republican senators, alarmed by a nonpartisan report showing millions would lose insurance under the GOP health-care plan, warned Tuesday that the bill wouldn ’t become law without fundamental changes. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 15, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

FDA Panel: Painkiller Opana ER Benefits No Longer Outweigh Risks
The benefits of an opioid painkiller linked to a 2015 HIV outbreak in Indiana no longer outweigh the risks, a panel of advisers to the U.S. Food and Drug Administration concluded Tuesday. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 15, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

After CBO Report, Democrats See Opening on Health Care
Democrats, after playing defense on health care for nearly a decade, are trying to turn the issue to their advantage in next year ’s midterm elections, targeting in particular lawmakers who have already voted for the GOP health bill. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 15, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Generic Drugmakers Can Live With a Speedier FDA
FDA chief nominee Scott Gottlieb ’s changes may pressure generic drug prices, but there are other positives for the sector. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 14, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

AstraZeneca Gives Rejected Drugs a Second Life
AstraZeneca is working with outside researchers to look for untapped potential in drugs that the company has shelved, part of a broader move to improve its research-and-development output. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 14, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news

Pershing Square Sold Stake in Valeant
William Ackman ’s Pershing Square sold its stake in struggling drugmaker Valeant Pharmaceuticals, taking a roughly $4 billion loss and bringing to a close one of the most tortured sagas in hedge-fund history. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 14, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

CBO Sees 24 Million More Uninsured, $337 Billion Deficit Cut With GOP Plan
The number of Americans without health insurance would grow by 24 million under a House Republican proposal to topple most of the Affordable Care Act, according to a nonpartisan report that is likely to complicate GOP lawmakers ’ efforts to unite around the plan. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 14, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

After Record Year for Fatal Overdoses, New York City Targets Opioids
New York City will spend $38 million annually to combat an opioid epidemic that killed more than 1,000 New Yorkers last year, city officials said  Monday. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 14, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Seema Verma Confirmed as Head of Centers for Medicare and Medicaid Services
Seema Verma, President Donald Trump ’s pick to oversee the Medicare and Medicaid programs, won Senate confirmation in a largely party-line vote Monday, placing an advocate of overhauling Medicaid at the program’s helm. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 13, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

GOP Health Plan Would Hit Rural Areas Hard
The House Republican effort to overhaul the Affordable Care Act could hit many rural areas particularly hard, sharply increasing the cost for some residents buying their own insurance. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 13, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

GOP Health Plan Advances After Clearing Two Panels
Republicans in Congress scored a victory in their efforts to replace parts of the Affordable Care Act, pushing measures through two House committees. But opposition to the health overhaul remains strong. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 10, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Soda Loses Its U.S. Crown: Americans Now Drink More Bottled Water
Americans now officially drink more bottled water than soda. It ’s a shift that decades ago might have seemed unthinkable—that consumers would buy a packaged version of something that was free from a tap. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 10, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Alliance of Companies Unveil First Steps to Cutting Health-Care Costs
A U.S. alliance formed last year by more than three dozen companies, including American Express Co., Johnson& Johnson and Macy ’s Inc., is announcing its first plans aimed at lowering the companies’ health-care spending. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 8, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news

GOP's Health Plan Draws Skepticism on Capitol Hill
President Donald Trump on Tuesday backed House Republicans ’ proposal to repeal and replace the Affordable Care Act, but emerging conservative opposition threatened to derail the contentious plan. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 8, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Health-Care Companies See Big Risks in Plan to Replace Obamacare
Though they are applauding the elimination of some taxes, insurers foresee problems from the cancellation of penalties for going without health coverage. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 8, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Lawmaker Tries to Steer Through Tricky Terrain on ACA
As Republicans dive into their politically risky push to undo the Affordable Care Act, Rep. Greg Walden is emerging as a key figure in the party ’s attempt to rally around a new health-insurance system. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 7, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

House Republicans Release Plan to Replace Obamacare
House Republicans released a detailed proposal that marks their first attempt in the new Congress to unite GOP members behind a plan to replace the Affordable Care Act and deliver on a central campaign promise. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 7, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Bird Flu Found at Farm Affiliated With Tyson
The first case of highly pathogenic avian influenza to strike a commercial poultry flock in more than a year has been found on a Tennessee chicken farm affiliated with Tyson Foods. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 6, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Race Tightens for Next Wave of Cancer Drugs
Incyte, which operates out of an old department store in Delaware, is one of the closest to market with a new class of immunotherapies. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 6, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news

Marathon Faces Scrutiny for Price of Muscular Dystrophy Drug
A group of U.S. senators is examining Marathon Pharmaceuticals LLC ’s decision to charge $89,000 in the U.S. for an old steroidal drug that costs a fraction of that overseas, the latest sign of growing scrutiny of the company. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 6, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news

New Jersey Complex Finds New Life as a Home for Several Firms
A 110-acre research complex in Bridgewater, N.J., seemed poised a few years ago to join the growing ranks of suburban office campuses left for dead, but a joint venture of investors is breathing life into the property. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 6, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Actelion's Founding Couple Starts New Biotech, With J & J's Backing
The founders of Swiss biotech company Actelion, which has been sold to J&J, are starting over again —creating a new biotech player with nearly $1 billion in capital, a deep-pocketed partner in J&J and soon, a stock listing in Zurich. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 3, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Roche Shares Boosted by Cancer Drug Trial Success
Roche shares rose sharply after the company reported a clinical trial success that could help cushion it against looming competition for Herceptin and boost sales for its newer Perjeta drug. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 2, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news

Drug Companies Block Shareholders' Voting on Price Transparency
Several major U.S. drug companies, including Pfizer and Merck, have squelched an investor campaign aimed at forcing companies to disclose more information about when and why they raise prices. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 2, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news

Valeant's Revenue Falls 13%
Valeant Pharmaceuticals said its revenue fell 13% in the fourth quarter, hurt by the performance of the stomach-drug business it tried to sell late last year as well as lower drug prices. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 1, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Johnson & Johnson Prescription Unit List Prices Rose 8.5% Last Year
Johnson& Johnson said it raised the list price of its prescription medicines by an average of 8.5% last year —and 3.5% after discounts—in the health-products company’s first effort to address criticism about the high cost of medicines by opening up about its drug-pricing practices. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 27, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

How to Get Patients to Take More Control of Their Medical Decisions
For years, people have been urged be more active in their own care. Now providers are giving them better tools to make that happen. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 27, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news

GOP Leaders Dare Fellow Republicans to Block Obamacare Repeal
Republican leaders are betting that the only way for Congress to repeal the Affordable Care Act is to set a bill in motion and gamble that fellow GOP lawmakers won ’t dare to block it. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 27, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

GOP Governors at Health-Law Impasse
Governors meeting Saturday to discuss health-care policy said they hadn ’t reached a consensus on the future of the Medicaid program, an issue hamstringing Republicans’ bid to alter the Affordable Care Act. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 27, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Facing Criticism, Drug Makers Keep Lid On Price Increases
Pharmaceutical companies held most of their traditional January list-price increases to under 10% this year, although the median boost was little-changed from 2016. Among the critics they face now is President Trump. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 27, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news

Trump Administration Seeks Delay in Lawsuit Over Health-Law Subsidies
The Trump administration and House Republicans on Tuesday asked a court for a further delay in a lawsuit over certain Affordable Care Act subsidies, a move that may help assuage insurers debating whether to participate in the health law ’s 2018 exchanges. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 22, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Carl Icahn Takes Stake in Bristol-Myers
The same day Bristol-Myers Squibb Co. shook up its board to satisfy one activist investor, the drugmaker was faced with another: Carl Icahn, whose interest is fueling speculation the company could soon be put on the auction block. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 22, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Tyson Seeks Lead in No-Antibiotics Poultry
Tyson Foods Inc. plans to eliminate antibiotics used on poultry in its flagship chicken products, as the largest U.S. meat company mounts a new push to burnish its brands. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 21, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Trump Backing for Bayer's Monsanto Deal Buoys Investors
Investors in Bayer have taken heart from President Donald Trump ’s apparent support for the German pharmaceuticals and chemicals firm’s planned $57 billion takeover of U.S. seed giant Monsanto. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 21, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Antitrust Rulings Put Chill on Health-Insurance Mergers
Cigna called off the roughly $48 billion merger with Anthem and filed a lawsuit against its suitor, the second such health-insurer deal to fall apart. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 15, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Door Opens to Gene Editing in Embryos
The nonprofit National Academies of Sciences and the National Academy of Medicine commissioned a study of the ethical, scientific and regulatory questions raised by editing genes in sperm, eggs and early-stage embryos. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 15, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Merck Stops Clinical Trial of Alzheimer's Drug
Merck& Co. said Tuesday it stopped a clinical trial of an experimental Alzheimer ’s drug because it wasn’t helping patients. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 14, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news

Teva Swings to Loss, But Beats Expectations
Teva Pharmaceuticals swung to a loss on an acquisition write-down, as its interim CEO contends with a deal-driven debt load, though shares rose as the company beat revenue and profit expectations. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 14, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

No Drugs for Back Pain, New Guidelines Say
The American College of Physicians says back pain of all kinds should be treated with natural and alternative therapies, such as exercise, acupuncture and mindfulness. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 14, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news

Firm Delays Muscular Dystrophy Drug Launch Amid Criticism of $89,000 Price
Marathon Pharmaceuticals will delay the U.S. launch of its muscular dystrophy drug amid mounting criticism of its $89,000-a-year price, including from two members of Congress who launched an investigation Monday. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 14, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news

The Rise and Fall of a K Street Renegade
Evan Morris, a high-flying corporate lobbyist, is suspected by federal prosecutors of embezzling millions of dollars from his employers, Roche and then Genentech. The probe is shaping up to be one of the biggest Washington influence scandals in years. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 13, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news

Allergan to Buy Fat-Treatment Maker Zeltiq for $2.3 Billion
Allergan PLC said it would buy Zeltiq Aesthetics Inc., the maker of a fat-reducing treatment, for $2.26 billion. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 13, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Hospitals Weigh Difficult Choice Amid Travel-Ban Uncertainty
Hospital officials say President Donald Trump ’s executive order leaves them with a difficult choice: forgo strong residency candidates from countries named in the order or risk vacancies if foreign doctors are barred from the U.S. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 13, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

70-Fold Price Increase Puts Drug at $89,000
Marathon Pharmaceuticals will charge $89,000 annually in the U.S. for a decades-old steroidal drug that was approved for U.S. sale for the first time on Thursday, a price that is as much as 70 times higher than the drug ’s price overseas. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 11, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news

Reckitt Benckiser to Buy Mead Johnson for $16.6 Billion
Reckitt Benckiser said it agreed to buy baby-food maker Mead Johnson for $16.6 billion, a cash deal that will almost double the size of the British company ’s consumer-health business and help it push deeper into emerging markets. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 10, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

As HHS Head, Price Has Wide Latitude to Shape Obamacare's Fate
The Georgia Republican was approved in a party-line vote Friday morning, placing him atop a sprawling agency tasked with dismantling the Affordable Care Act. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 10, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Federal Judge Blocks Anthem's Planned Cigna Buy
The decision said the proposed $48 billion deal violated antitrust law because it would create an unacceptable reduction in the number of companies serving large national employers that insure their workers. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 9, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news